Pennant Investors, LP Altimmune, Inc. Transaction History
Pennant Investors, LP
- $367 Million
- Q2 2024
A detailed history of Pennant Investors, LP transactions in Altimmune, Inc. stock. As of the latest transaction made, Pennant Investors, LP holds 109,800 shares of ALT stock, worth $819,108. This represents 0.2% of its overall portfolio holdings.
Number of Shares
109,800
Previous 109,800
-0.0%
Holding current value
$819,108
Previous $1.12 Million
34.65%
% of portfolio
0.2%
Previous 0.28%
Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
190Shares Held
42.2MCall Options Held
1.05MPut Options Held
582K-
Black Rock Inc. New York, NY5.32MShares$39.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$36.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.91MShares$29.2 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.22MShares$24.1 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$20.5 Million2.23% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $366M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...